Clinical Research Directory
Browse clinical research sites, groups, and studies.
Anti-Wrinkle Efficacy of a Syringic Acid-Containing Emulsion
Sponsor: BioSpectrum Inc
Summary
This randomized, double-blind, split-face controlled study was conducted to evaluate the anti-wrinkle efficacy and safety of a Syringic acid-containing emulsion in healthy female subjects. The test product was an emulsion containing 2% Synox, a Syringic acid-containing ingredient, while the control product was an emulsion without Synox. Participants applied the test and control products to opposite sides of the face according to random allocation for 12 weeks. Skin wrinkle-related parameters were evaluated at baseline and after 4, 8, and 12 weeks of product use using visual assessment, replica-based instrumental measurement, and subject questionnaires. Skin safety was monitored throughout the study period.
Official title: A Randomized, Double-Blind, Split-Face Controlled Study to Evaluate the Anti-Wrinkle Efficacy and Safety of a Syringic Acid-Containing Emulsion in Healthy Subjects
Key Details
Gender
All
Age Range
30 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
23
Start Date
2015-01-12
Completion Date
2015-04-17
Last Updated
2026-09-30
Healthy Volunteers
Yes
Conditions
Interventions
Synox-containing Emulsion
A cosmetic emulsion containing 2% Synox, a raw material containing 1% Syringic acid, was applied topically for 12 weeks.
Control Emulsion
A vehicle control emulsion without Synox was applied to the contralateral side of the face for 12 weeks.
Locations (1)
Dermapro Co., Ltd.
Seoul, South Korea